ArticleBMC pregnancy and childbirth2025
Risk factors and adverse pregnancy outcomes associated with large for gestational age infants in pregnant women with type 2 diabetes mellitus.
Article in BMC pregnancy and childbirth, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
objectiveTo investigate the risk factors for delivering large for gestational age (LGA) infants in patients with type 2 diabetes mellitus (T2DM) and their pregnancy outcomes.
methodsThis was a retrospective cohort study of T2DM patients who registered for regular prenatal care and delivered at the Beijing Obstetrics and Gynecology Hospital from January 1, 2012, to December 31, 2020. Patients were divided into the LGA and non-LGA groups to explore the risk factors and pregnancy outcomes associated with delivering LGA infants in T2DM patients.
results(1)A total of 691 T2DM patients were included, of which 257 delivered LGA infants, accounting for 37.19%. (2) Pre-pregnancy body mass index (OR: 1.067, 95%CI: 1.026-1.109), multiparity (OR: 2.455, 95%CI: 1.704-3.538), history of polycystic ovary syndrome (PCOS) (OR: 2.211, 95%CI: 1.283-3.810), late pregnancy glycosylated hemoglobin (HbA1c) (OR: 2.168, 95%CI: 1.567-3.001), gestational weight gain (OR: 1.073, 95%CI: 1.034-1.114), and female newborns (OR: 1.571, 95%CI: 1.109-2.225) were independent risk factors for delivering LGA infants in T2DM patients. (3) After adjusting for pre-pregnancy BMI, multiparity, history of PCOS, gestational weight gain, and late pregnancy HbA1c, delivering LGA infants in T2DM patients increased the risk of postpartum hemorrhage (OR: 1.872, 95%CI: 1.171-2.992), shoulder dystocia (OR: 6.046, 95%CI: 1.767-20.681), admission to the neonatal intensive care unit (OR: 1.542, 95%CI: 1.061-2.242), and neonatal hypoglycemia (OR: 1.991, 95%CI: 1.250-3.170).
conclusionStrengthening the identification of risk factors, improving pre-pregnancy weight management, ensuring adequate weight gain during pregnancy, and maintaining good glycemic control are important measures for T2DM patients to avoid delivering LGA infants and adverse pregnancy outcomes.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.